SYNERON MEDICAL LTD - M87245102

Sector: No information yet · Industry: No information yet
Website: No information yet · Social: No information yet

Company profile

Description is not available for this instrument yet.

Quarter snapshot

Latest / Compare
Q1 2017 · Q2 2014
Value (USD)
Total reported value ($000)
$54.26M
QoQ value delta ($000)
+$213K (+0.39%)
Implied price effect (QoQ)
+0.01%
Shares
Total shares
5,257,759
QoQ shares delta
+20,201 (+0.39%)
Total shares held by funds (by quarter)

Top holders (Q1 2017)

Top 25 only Full list
Partial Q1 2017 data: 1 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
BRANDES INVESTMENT PARTNERS, LP 21,442 2,077,630 0.26%
ROYCE & ASSOCIATES LLC 10,186 987,059 0.03%
GRANAHAN INVESTMENT MANAGEMENT INC/MA 9,182 889,705 0.27%
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. 5,834 565,290 0.78%
FRONTIER CAPITAL MANAGEMENT CO LLC 2,130 206,350 0.02%
VICTORY CAPITAL MANAGEMENT INC 1,346 130,397 0.01%
DAVENPORT & Co LLC 1,077 104,425 0.02%
Teton Advisors, Inc. 1,045 101,249 0.07%
TFS CAPITAL LLC 500 48,402 0.04%
Moors & Cabot, Inc. 456 44,551 0.08%
GAMCO INVESTORS, INC. ET AL 248 24,000 0.0%
IRIDIAN ASSET MANAGEMENT LLC/CT 213 20,664 0.0%
Federation des caisses Desjardins du Quebec 213 20,201 0.0%
BlackRock Group LTD 171 16,547 0.0%
GABELLI FUNDS LLC 144 14,000 0.0%
FIRST MERCANTILE TRUST CO 40 3,890 0.0%
Global X Management CO LLC 21 1,991 0.0%
BlackRock Institutional Trust Company, N.A. 7 683 0.0%
DAVIDSON D A & CO 5 500 0.0%
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 2 225 0.0%